Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
8.28
+0.38 (4.81%)
At close: Mar 4, 2026, 4:00 PM EST
8.28
0.00 (0.00%)
After-hours: Mar 4, 2026, 4:10 PM EST
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $752.57 million as of March 4, 2026. Its market cap has decreased by -26.80% in one year.
Market Cap
752.57M
Enterprise Value
693.69M
1-Year Change
-26.80%
Ranking
Category
Stock Price
$8.28
Market Cap Chart
Since October 31, 2023, Gyre Therapeutics's market cap has increased from $515.41M to $752.57M, an increase of 46.01%. That is a compound annual growth rate of 17.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 718.03M | 11.90% |
| Dec 31, 2025 | 641.69M | -38.21% |
| Dec 31, 2024 | 1.04B | -47.22% |
| Dec 29, 2023 | 1.97B | 281.72% |
| Oct 31, 2023 | 515.41M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prime Medicine | 825.00M |
| Annexon | 822.79M |
| Janux Therapeutics | 816.36M |
| KalVista Pharmaceuticals | 811.77M |
| Evommune | 807.33M |
| BridgeBio Oncology Therapeutics | 806.29M |
| Eikon Therapeutics | 803.29M |
| Bright Minds Biosciences | 796.87M |